N-Benzoyl-(2R,3S)-3-phenylisoserine
N-Benzoyl-(2R,3S)-3-phenylisoserine structure
|
Common Name | N-Benzoyl-(2R,3S)-3-phenylisoserine | ||
|---|---|---|---|---|
| CAS Number | 132201-33-3 | Molecular Weight | 285.29500 | |
| Density | 1.316g/cm3 | Boiling Point | 580.7ºC at 760 mmHg | |
| Molecular Formula | C16H15NO4 | Melting Point | 169-172 °C(lit.) | |
| MSDS | Chinese USA | Flash Point | 305ºC | |
| Symbol |
GHS07 |
Signal Word | Warning | |
|
Kingston, D.G.I. et al.
J. Nat. Prod. 53 , 1, (1990)
|
|
|
Mangatal, L. et al.
Tetrahedron 45 , 4177, (1989)
|
|
|
Borman, S.
Chem. Eng. News 69(35) , 11, (1991)
|
|
|
Ojima, I. et al.
Tetrahedron 48 , 6985, (1992)
|
|
|
Ojima, I. et al.
Tetrahedron Lett. 34 , 4149, (1993)
|
|
|
Holton, R.A. et al.
J. Am. Chem. Soc. 116 , 1597, (1994)
|
|
|
Sequences of taxol and cisplatin: a phase I and pharmacologic study.
J. Clin. Oncol. 9 , 1692, (1991) Untreated and minimally pretreated solid tumor patients received alternating sequences of taxol and cisplatin. Sequential dose escalation of each agent using taxol doses of 110 or 135 mg/m2 and cisplatin doses of 50 or 75 mg/m2 resulted in four dosage permuta... |
|
|
Taxol: twenty years later, the story unfolds.
J. Natl. Cancer Inst. 83 , 1778, (1991)
|